94 related articles for article (PubMed ID: 19571287)
1. Human idiopathic membranous nephropathy--a mystery solved?
Glassock RJ
N Engl J Med; 2009 Jul; 361(1):81-3. PubMed ID: 19571287
[No Abstract] [Full Text] [Related]
2. Quantity Versus Quality of Anti-Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues.
Beck LH
Am J Kidney Dis; 2024 May; 83(5):566-568. PubMed ID: 38260930
[No Abstract] [Full Text] [Related]
3. Hope or hype? Clinicians' dilemma in the era of ever-expanding antigens in membranous nephropathy.
Bonilla M; Hassanein M; Caza T; Jhaveri KD
Nephrol Dial Transplant; 2023 Nov; 38(12):2666-2669. PubMed ID: 37442615
[No Abstract] [Full Text] [Related]
4.
Takahashi-Kobayashi M; Usui J; Kawanishi K; Yamagata K
J Am Soc Nephrol; 2022 Dec; 33(12):2321-2322. PubMed ID: 36175143
[No Abstract] [Full Text] [Related]
5. Chimeric autoantibody receptor cell therapy for the treatment of membranous nephropathy.
Rovira J; Arana C; Garcia-Busquets A; Gille I; Quintana LF; Heemskerk MHM; Heidt S; Palou E; Diekmann F
Kidney Int; 2024 Jun; 105(6):1320. PubMed ID: 38777405
[No Abstract] [Full Text] [Related]
6. (T-) Regulation of Immunity in Membranous Nephropathy.
Mathew G; Sinha A
Indian J Pediatr; 2024 Jul; 91(7):657-658. PubMed ID: 38556614
[No Abstract] [Full Text] [Related]
7. Membranous nephropathy: from models to man.
Beck LH; Salant DJ
J Clin Invest; 2014 Jun; 124(6):2307-14. PubMed ID: 24892704
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care.
Ronco P; Debiec H
Lancet; 2015 May; 385(9981):1983-92. PubMed ID: 26090644
[TBL] [Abstract][Full Text] [Related]
9. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.
Xu X; Wang G; Chen N; Lu T; Nie S; Xu G; Zhang P; Luo Y; Wang Y; Wang X; Schwartz J; Geng J; Hou FF
J Am Soc Nephrol; 2016 Dec; 27(12):3739-3746. PubMed ID: 27365535
[TBL] [Abstract][Full Text] [Related]
11. Membranous Nephropathy: Core Curriculum 2021.
Alsharhan L; Beck LH
Am J Kidney Dis; 2021 Mar; 77(3):440-453. PubMed ID: 33487481
[TBL] [Abstract][Full Text] [Related]
12. Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.
Ruggenenti P; Debiec H; Ruggiero B; Chianca A; Pellé T; Gaspari F; Suardi F; Gagliardini E; Orisio S; Benigni A; Ronco P; Remuzzi G
J Am Soc Nephrol; 2015 Oct; 26(10):2545-58. PubMed ID: 25804280
[TBL] [Abstract][Full Text] [Related]
13. Primary Membranous Nephropathy.
Couser WG
Clin J Am Soc Nephrol; 2017 Jun; 12(6):983-997. PubMed ID: 28550082
[TBL] [Abstract][Full Text] [Related]
14. Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.
Miao H; Zhang Y; Yu X; Zou L; Zhao Y
Front Pharmacol; 2022; 13():969930. PubMed ID: 36176440
[TBL] [Abstract][Full Text] [Related]
15. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
Front Immunol; 2019; 10():1809. PubMed ID: 31447839
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
Zhang D; Zou J; Zhang C; Zhang W; Lin F; Jiang G
Med Sci Monit; 2018 Jul; 24():5076-5083. PubMed ID: 30032157
[TBL] [Abstract][Full Text] [Related]
17. An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN.
Ren S; Wu C; Zhang Y; Wang AY; Li G; Wang L; Hong D
Ren Fail; 2018 Nov; 40(1):306-313. PubMed ID: 29623759
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).
Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA
Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial.
Chen Y; Deng Y; Ni Z; Chen N; Chen X; Shi W; Zhan Y; Yuan F; Deng W; Zhong Y
Am J Kidney Dis; 2013 Dec; 62(6):1068-76. PubMed ID: 23810688
[TBL] [Abstract][Full Text] [Related]
20. Identification of biomarkers related to immune and inflammation in membranous nephropathy: comprehensive bioinformatic analysis and validation.
Zhang P; Geng Y; Tang J; Cao Z; Xiang X; Yang K; Chen H
Front Immunol; 2023; 14():1252347. PubMed ID: 37876929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
